{"version":"1.0","provider_name":"INCYTE","provider_url":"https:\/\/incyteonco.ca\/fr\/","title":"PEMAZYRE PATIENTS - INCYTE","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"uhUPBTAgGt\"><a href=\"https:\/\/incyteonco.ca\/fr\/pemazyre-patients\/\">PEMAZYRE PATIENTS<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/incyteonco.ca\/fr\/pemazyre-patients\/embed\/#?secret=uhUPBTAgGt\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0PEMAZYRE PATIENTS\u00a0\u00bb &#8212; INCYTE\" data-secret=\"uhUPBTAgGt\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/incyteonco.ca\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"PrPEMAZYREMD b\u00e9n\u00e9ficie d\u2019une autorisation de mise en march\u00e9 avec conditions, en attendant les r\u00e9sultats des \u00e9tudes pour v\u00e9rifier son bienfait clinique. Les patients doivent \u00eatre inform\u00e9s de cette autorisation de mise en march\u00e9 avec conditions. Les outils les plus r\u00e9cents sur PEMAZYREMD regroup\u00e9s au m\u00eame endroit PEMAZYREMD (pemigatinib) est indiqu\u00e9 pour le traitement des adultes [&hellip;]","thumbnail_url":"https:\/\/incyteonco.ca\/wp-content\/uploads\/2025\/09\/Pemazyre-Logo-FR.png","thumbnail_width":1444,"thumbnail_height":538}